Intuitive Surgical Inc buy Mr_Schulz
Summary
This prediction ended on 04.03.13 with a price of €140.00. With a performance of 7.67%, the BUY prediction by Mr_Schulz for Intuitive Surgical Inc closed with a slight gain. Mr_Schulz has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intuitive Surgical Inc | -2.248% | -2.248% | -7.382% | 89.249% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by Mr_Schulz for this prediction
In the thread Intuitive Surgical Inc diskutieren
...again and yet again! , )
Intuitive Surgical balances risk with potential long-term reward
Consider Intuitive Surgical (Nasdaq: ISRG) for your portfolio. It carries more risk than many companies, but it offers more potential reward as well. The company is the biggest player in the robotic surgical equipment arena, selling hospitals its “da Vinci” machines that permit surgeons to perform procedures in less invasive ways.
In the company’s last quarter, revenue was up 26 percent over year-ago levels and earnings grew by 32 percent. The company has no debt and generates solid cash flow. Better still, the company doesn’t make money only by selling its million-dollar machines – a little more than half its revenue is recurring, from service contracts and supplies and accessories for the machines.
Then there are procedures. Most of the procedures its machines perform are hysterectomies and prostatectomies, but the company is working to get approval for new procedures. If and when it succeeds, significant new revenue streams will open up. International sales represent another avenue to growth.
Intuitive Surgical seems like a promising long-term investment. Learn more before you jump in, or perhaps just add it to your watch list and hope for a lower price. Its stock price, recently near $500 per share, may not be a screaming bargain, but it doesn’t seem severely overvalued, either.
Source: www.spokesman.com